Skip to main content
. Author manuscript; available in PMC: 2022 Jun 14.
Published in final edited form as: Cancer Cell. 2021 Jun 14;39(6):793–809.e8. doi: 10.1016/j.ccell.2021.05.008

Figure 3. Genetic and clinical features of molecular subtypes in UTUC.

Figure 3.

(A) Frequencies of common genetic lesions and clinical/histological features across four non-hypermutated subtypes. Genes affected in more than two subtypes (CDKN2A, TERT promoter, and MDM2) are listed on the top. (B) Disease-specific survival for patients in each mutational subtype. Hazard ratios (HRs) and 95% CIs were calculated by Cox proportional-hazards model.

See also Figures S4 and S5.